Brought to you by 
Zentiva closes €84.8mm IPO
09 Jul 2004
Executive Summary
In a five-times oversubscribed offering, generic drug company Zentiva BV has raised €84.85mm ($102.7mm) with a 5.6mm-share IPO, pricing its common shares at €15.24 ($18.36) apiece. The firm will trade on the Prague Stock Exchange; its global depositary shares (each of which equals one common share) will be listed on the London Stock Exchange. Zentiva's majority shareholder Warburg Pincus is selling $100mm in a secondary offering, leaving Pincus with a slightly over 50% stake in the company.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zentiva closes €84.8mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice